Divisadero Street Capital Management’s Fulgent Genetics FLGT Stock Holding History

Divisadero Street Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-505,212	Closed	-$9.91M	–	79
2024 Q2	$9.91M	Buy	505,212 +160,212	+46%	+$3.34M	1.5%	18
2024 Q1	$7.49M	Buy	345,000 +207,689	+151%	+$5.16M	1.75%	14
2023 Q4	$3.97M	Sell	137,311 -722,689	-84%	-$19.3M	0.9%	30
2023 Q3	$23M	Buy	860,000 +166,788	+24%	+$5.69M	7.25%	2
2023 Q2	$25.7M	Buy	693,212 +326,712	+89%	+$11.4M	7.42%	2
2023 Q1	$11.4M	Buy	+366,500	New	+$11.8M	5.01%	7
2022 Q1	–	Sell	-26,900	Closed	-$2.71M	–	48
2021 Q4	$2.71M	Buy	+26,900	New	+$2.36M	2.26%	17

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Divisadero Street Capital Management's FLGT Position: Q3 2024 in Review

Divisadero Street Capital Management sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 505,212 shares — an estimated $9.91M sold.

Divisadero Street Capital Management first reported a position in FLGT in Q4 2021 and held it in 7 quarters. The position peaked at $25.7M in Q2 2023. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

Divisadero Street Capital Management reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
Divisadero Street Capital Management sold 505,212 Fulgent Genetics shares in Q3 2024, an estimated $9.91M.
Divisadero Street Capital Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 7 quarters.
Divisadero Street Capital Management's Fulgent Genetics position peaked at $25.7M in Q2 2023.
183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Divisadero Street Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.